We recently published a list of Michael Burry’s Top Holdings Were Gaining While NVDA Was Crashing. In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against ...

BioAFM is seeing increasingly widespread use in biomedical and biological studies due to its extremely high resolution and its capacity to perform experiments with live cells in liquid and under ...

Equities researchers at Zacks Research lifted their FY2025 earnings per share estimates for shares of Bruker in a research ...

Bruker Co. (NASDAQ:BRKR – Get Free Report) has received a consensus rating of “Moderate Buy” from the eleven analysts that are presently covering the company, Marketbeat Ratings reports. Five research ...

The newly acquired ELITech Molecular Diagnostics business also contributed, positioning Bruker as an emerging infectious disease specialist in the in-vitro diagnostics (IVD) market. Within Bruker’s ...